Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why Geron Stock Crept Higher Today
Why Geron Stock Crept Higher Today

Shares of commercial-stage biotech Geron (NASDAQ: GERN) couldn't quite surmount the hump of Hump Day. After the company released its latest set of quarterly figures, its stock price wobbled as

What's Going On With AMD Stock After Earnings?
What's Going On With AMD Stock After Earnings?

In this video, I will cover Advanced Micro Devices' (NASDAQ: AMD) recent earnings report and explain why the stock barely moved after a strong earnings beat. Watch the short video to learn more

Why Rigetti Computing Stock Soared in April
Why Rigetti Computing Stock Soared in April

Shares of Rigetti Computing (NASDAQ: RGTI) surged higher in April. The company's stock gained 12% over the course of the month. The strong performance came as the S&P 500 and the Nasdaq Composite

Is AT&T Stock a Buy Now?
Is AT&T Stock a Buy Now?

Venerable telecom titan AT&T (NYSE: T) is on a roll. Its shares soared to a 52-week high of $29.03 in April, the highest it's been since before the COVID-19 pandemic.This result is a dramatic

Lisa Su Just Gave Amazing News to AMD Stock Investors
Lisa Su Just Gave Amazing News to AMD Stock Investors

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

Can Summit Therapeutics Stock Double Your Money?
Can Summit Therapeutics Stock Double Your Money?

Summit Therapeutics (NASDAQ: SMMT) has more than just a potential blockbuster cancer drug in its portfolio. Ivonescimab could be one of the best drugs to ever hit the market. This has investors

AMD Stock Pops on Earnings Beat as AI Chip Revenue Grows by "Significant Double-Digit Percentage"
AMD Stock Pops on Earnings Beat as AI Chip Revenue Grows by "Significant Double-Digit Percentage"

Shares of Advanced Micro Devices (NASDAQ: AMD) rose 1.8% in Tuesday's after-hours trading, following the chipmaker's release of its first-quarter 2025 report.

The stock's gain is attributable to

EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-News: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
EQS-Adhoc: Change of President and CEO at Carl Zeiss Meditec AG
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after

EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
EQS-News: Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit.
Why Vertex Pharmaceuticals Stock Is Sinking Today
Why Vertex Pharmaceuticals Stock Is Sinking Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday

VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap:  Expanding Sales Network, New Product Launches,  & Growth in Pharmacy and Online Sales
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network becomes a partner of Mayo Clinic Care Network
Rising Costs Weigh on Vertex Q1 Earnings
Rising Costs Weigh on Vertex Q1 Earnings

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) first-quarter financial report.

Vertex's first-quarter financial results didn't keep up with what investors have gotten used to

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

One of the best catalysts for a stock's rise is the withdrawal of a rival. That was an important dynamic behind the double-digit-percentage rise of biotech Viking Therapeutics' (NASDAQ: VKTX) stock

Got $1,000? 2 Top Growth Stocks to Buy That Could Double Your Money
Got $1,000? 2 Top Growth Stocks to Buy That Could Double Your Money

The concerns around tariffs and the impact on the economy triggered a sharp sell-off for stocks recently. But this uncertainty hasn't seemed to slow the momentum for the artificial intelligence (AI)

EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
EQS-News: Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment
Will This Be the Catalyst AMD Stock Investors Are Waiting For?
Will This Be the Catalyst AMD Stock Investors Are Waiting For?

In today's video, I discuss Advanced Micro Devices (NASDAQ: AMD) and what investors should know before the company reports earnings. To learn more, check out the short video, consider subscribing,

3 No-Brainer Stocks to Buy in May
3 No-Brainer Stocks to Buy in May

Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the

Prediction: This Will Be the Top-Performing Semiconductor Stock Over the Next 10 Years (Hint: It's Not Nvidia)
Prediction: This Will Be the Top-Performing Semiconductor Stock Over the Next 10 Years (Hint: It's Not Nvidia)

The launch of ChatGPT on Nov. 30, 2022 represented one of the leading catalysts that sparked the revolution around artificial intelligence (AI). Since that date, shares of semiconductor stock Nvidia

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns usually don't affect drugmakers' underlying

This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy

Medical device specialist Medtronic (NYSE: MDT) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?

Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those